3 news items
Spotlighting Unexplored Stocks in Focus: NKGN, INBS, BTBT, PRSO, MGOL
BTBT
INBS
MGOL
24 May 24
with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data In Alzheimer's Disease At The Tau2024 Global Conference
NKGN
25 Mar 24
one year in which we expect to show an even greater clinical benefit. We are excited to continue our research with the goal of offering our NK cell
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer's Disease at the Tau2024 Global Conference
NKGN
25 Mar 24
with the goal of offering our NK cell therapy to patients with Alzheimer's disease who are in need of disease modifying treatments
- Prev
- 1
- Next